PharmaCielo Ltd. (PCLOF)
- Previous Close
0.1240 - Open
0.1117 - Bid --
- Ask --
- Day's Range
0.1117 - 0.1173 - 52 Week Range
0.0790 - 0.2200 - Volume
15,220 - Avg. Volume
11,360 - Market Cap (intraday)
19.986M - Beta (5Y Monthly) 2.48
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date May 7, 2024 - May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. The company also offers telemedicine software. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. PharmaCielo Ltd. has strategic partnership with Benuvia Operations, LLC to manufacture cGMP pharmaceutical-grade CBD isolate and related products. PharmaCielo Ltd. is headquartered in Toronto, Canada.
www.pharmacielo.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: PCLOF
Performance Overview: PCLOF
Trailing total returns as of 5/7/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PCLOF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PCLOF
Valuation Measures
Market Cap
19.94M
Enterprise Value
32.20M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.45
Price/Book (mrq)
10.37
Enterprise Value/Revenue
11.46
Enterprise Value/EBITDA
-3.59
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-22.86%
Return on Equity (ttm)
-214.57%
Revenue (ttm)
2.81M
Net Income Avi to Common (ttm)
-12.82M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
24.17k
Total Debt/Equity (mrq)
602.97%
Levered Free Cash Flow (ttm)
-4.42M
Company Insights: PCLOF
PCLOF does not have Company Insights